iodofiltic acid has been researched along with Kidney Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inoue, T; Ishigami, T; Ishikawa, T; Kimura, K; Sugano, T; Takahashi, N; Takamura, T; Uchino, K; Umemura, S | 1 |
Iwamoto, N; Kikuchi, K; Nishimura, M; Ono, T; Tamaki, N; Tsukamoto, K | 1 |
2 other study(ies) available for iodofiltic acid and Kidney Diseases
Article | Year |
---|---|
Combining chronic kidney disease with 201thallium/123iodine beta methyliodophenyl pentadecanoic acid dual myocardial single-photon emission computed tomography findings is useful for the evaluation of cardiac event risk.
Topics: Aged; Chronic Disease; Fatty Acids; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart; Heart Diseases; Humans; Iodobenzenes; Kaplan-Meier Estimate; Kidney Diseases; Male; Multivariate Analysis; Myocardium; Prognosis; Risk; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2009 |
Risk stratification for cardiac death in hemodialysis patients without obstructive coronary artery disease.
Topics: Aged; Cause of Death; Chi-Square Distribution; Chronic Disease; Coronary Angiography; Coronary Circulation; Disease-Free Survival; Fatty Acids; Female; Heart Diseases; Humans; Insulin Resistance; Iodobenzenes; Japan; Kaplan-Meier Estimate; Kidney Diseases; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Renal Dialysis; Risk Assessment; Risk Factors; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2011 |